Avidity biosciences to participate in upcoming investor conference

San diego , nov. 26, 2024 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating in the following upcoming conference: 7th annual evercore isi healthconx conference on december 3 at 9:30 a.m. pt / 12:30 p.m.
RNA Ratings Summary
RNA Quant Ranking